Earlier Nutrient Fortification of Breastmilk Fed LBW Infants Improves Jaundice Related Outcomes

Xiao Wei Ma1, Wei Qi Fan1,2

  • 1Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Grattan Street, Melbourne, VIC 3010, Australia.

Nutrients
|July 26, 2020
PubMed

Insights

Earlier nutrient supplementation for premature infants significantly improved jaundice outcomes and reduced feeding intolerance. This approach also led to shorter hospital stays and faster birth weight regain, with no adverse effects.

Area of Science:

  • Neonatalogy
  • Pediatric Gastroenterology
  • Clinical Nutrition

Background:

  • Jaundice is a common condition in low-birthweight premature infants.
  • Nutrient supplementation timing is a critical factor in neonatal care.
  • Previous research has not fully elucidated the impact of early versus late nutrient administration on jaundice and related outcomes.

Purpose of the Study:

  • To evaluate the effect of earlier versus later nutrient supplementation on jaundice outcomes in low-birthweight premature infants.
  • To compare clinical outcomes, including feeding intolerance and length of stay, between the two supplementation groups.

Main Methods:

  • A comparative study involving low-birthweight premature infants receiving either early (80 mL/kg/day) or late (160 mL/kg/day) nutrient supplementation.
  • Collection of data on demographics, feeding regimens, and clinical outcomes, including serum bilirubin levels and phototherapy use.
  • Statistical analysis to compare jaundice parameters, feeding intolerance, length of stay, and weight changes between groups.

Main Results:

  • Earlier nutrient supplementation (F80) was associated with significantly lower total serum bilirubin (TSBR) and conjugated serum bilirubin (CSBR) values.
  • F80 group showed reduced need for phototherapy (39% vs. 64%), decreased feeding intolerance (26.0% vs. 45.2%), and shorter length of stay (16.0 vs. 18.8 days).
  • F80 infants experienced less maximum weight loss, improved weight Z-score at 10 days, and earlier regain of birthweight compared to the F160 group.

Conclusions:

  • Earlier nutrient supplementation in low-birthweight premature infants positively impacts jaundice outcomes, potentially through enhanced bilirubin excretion.
  • Early supplementation also confers benefits such as reduced feeding intolerance, shorter hospital stays, and improved weight gain dynamics.
  • These findings suggest that optimizing the timing of nutrient supplementation is a valuable strategy in managing premature neonates.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
542
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
153
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.8K
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
530
Microbial Nutrition01:28

Microbial Nutrition

Organisms exhibit remarkable metabolic diversity, categorized based on how they acquire energy and carbon. These strategies enable survival in various ecological niches and are essential for maintaining energy flow and nutrient cycling within ecosystems.Energy and Carbon SourcesOrganisms are classified as phototrophs or chemotrophs based on energy acquisition. Phototrophs use light as their energy source, while chemotrophs rely on oxidizing chemical compounds. Further differentiation arises...
878
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
637